Mathematical modeling of mutant transferrin-CRM107 molecular conjugates for cancer therapy

DOI10.1016/J.JTBI.2017.01.008MaRDI QIDQ2013435zbMATH OpenOpenAlexWikidataFDO

Authors Dennis J. Yoon, Kevin Y. Chen, André M. Lopes, April A. Pan, Joseph Shiloach, Anne B. Mason, Daniel T. Kamei

Publication date 18 August 2017

Published in Journal of Theoretical Biology (Search for Journal in Brave)

Full work available at URL http://europepmc.org/articles/pmc5310938

zbMATH Keywords

diphtheria toxindrug deliverytargeted toxin

Mathematics Subject Classification ID

Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45) Medical applications (general) (92C50)

Recommendations

• Mathematical modeling and analysis of CD200-CD200R in cancer treatment
• Mathematical modeling and optimization of intratumor drug transport
• Development and Validation of a Mathematical Model to Describe Anti-Cancer Prodrug Activation by Antibody-Enzyme Conjugates
• Mathematical modeling of chemotherapy strategies in vascular tumor growth using nanopar\-ti\-cles
• Modeling the transfer of drug resistance in solid tumors
• scientific article; zbMATH DE number 1262330
• Mathematical model creation for cancer chemo-immunotherapy
• Mathematical modelling of cancer stem cell-targeted immunotherapy
• A NEW MATHEMATICAL MODELING AND SUB-OPTIMAL CHEMOTHERAPY OF CANCER
• Mathematical model of optimal chemotherapy and oncolytic virotherapy

Cited in

(3)

• Theoretical analysis of conjugate localization in two-step cancer chemotherapy
• The natural anticancer agent cucurbitacin inhibits specifically the stem cell factor binding to its receptor, c-kit
• Development and Validation of a Mathematical Model to Describe Anti-Cancer Prodrug Activation by Antibody-Enzyme Conjugates

This page was built for publication: Mathematical modeling of mutant transferrin-CRM107 molecular conjugates for cancer therapy

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2013435)